Aspirin, caffeine (Aspirin And Caffeine)
Aspirin, caffeine
Hoechst Marion Roussel Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Hoechst Marion Roussel Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Aspirin and caffeine tablets EACH TABLET CONTAINS ASPIRIN 300 mg CAFFEINE 30 mg | Tablets | B1358B/2.8/1358 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S3: Caffeine
- when intended for injection.
Consolidated Schedules 06 July 2026, line 3256
S2: Aspirin
- the treatment of children or adolescents; and
- the prophylaxis of cardiovascular disease in adults (S0)
Consolidated Schedules 06 July 2026, lines 1616 to 1620
1 of 10 approved products with this ingredient carry S5 on their leaflet.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.